Site 02-008 - MidLantic Urology — Bala-Cynwyd, Pennsylvania

Site 02-008 - MidLantic Urology is a clinical research site located in Bala-Cynwyd, Pennsylvania, United States 19004.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site 02-008 - MidLantic Urology has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG.

Sponsors: Theralase® Technologies Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 02-008 - MidLantic Urology?

Site 02-008 - MidLantic Urology has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 02-008 - MidLantic Urology conducted?

Site 02-008 - MidLantic Urology has 1 clinical trials on record, with 1 currently active. Their work covers Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG.

Is Site 02-008 - MidLantic Urology accredited by Crixeo Health?

Site 02-008 - MidLantic Urology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 02-008 - MidLantic Urology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.